The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck, hepatocellular, lung, neuroblastoma, ovarian, pancreatic, prostate, renal and other cancers have been keenly investigated since the 1980's. While the receptors and many downstream signaling molecules have been identified and characterized, there is still much to learn about this pathway and how its deregulation can lead to cancer and how it may be differentially regulated in various cell types. Multiple inhibitors to EGFR family members have been developed and many are in clinical use. Current research often focuses on their roles and other associated pathways in cancer stem cells (CSCs), identifying sites where therapeutic resistance may develop and the mechanisms by which microRNAs (miRs) and other RNAs regulate this pathway. This review will focus on recent advances in these fields with a specific focus on breast cancer and breast CSCs. Relatively novel areas of investigation, such as treatments for other diseases (e.g., diabetes, metabolism, and intestinal parasites), have provided new information about therapeutic resistance and CSCs.

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy / Steelman, Linda S; Fitzgerald, Timothy; Lertpiriyapong, Kvin; Cocco, Lucio; Follo, Matilde Y; Martelli, Alberto M; Neri, Luca M; Marmiroli, Sandra; Libra, Massimo; Candido, Saverio; Nicoletti, Ferdinando; Scalisi, Aurora; Fenga, Concettina; Drobot, Lyudmyla; Rakus, Dariusz; Gizak, Agnieszka; Laidler, Piotr; Dulinska Litewka, Joanna; Basecke, Joerg; Mijatovic, Sanja; Maksimovic Ivanic, Danijela; Montalto, Giuseppe; Cervello, Melchiorre; Milella, Michelle; Tafuri, Agustino; Demidenko, Zoya; Abrams, Stephen L; Mccubrey, James A.. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1873-4286. - 22:16(2016), pp. 2358-2388. [10.2174/1381612822666160304151011]

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy

MARMIROLI, Sandra;
2016-01-01

Abstract

The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck, hepatocellular, lung, neuroblastoma, ovarian, pancreatic, prostate, renal and other cancers have been keenly investigated since the 1980's. While the receptors and many downstream signaling molecules have been identified and characterized, there is still much to learn about this pathway and how its deregulation can lead to cancer and how it may be differentially regulated in various cell types. Multiple inhibitors to EGFR family members have been developed and many are in clinical use. Current research often focuses on their roles and other associated pathways in cancer stem cells (CSCs), identifying sites where therapeutic resistance may develop and the mechanisms by which microRNAs (miRs) and other RNAs regulate this pathway. This review will focus on recent advances in these fields with a specific focus on breast cancer and breast CSCs. Relatively novel areas of investigation, such as treatments for other diseases (e.g., diabetes, metabolism, and intestinal parasites), have provided new information about therapeutic resistance and CSCs.
feb-2016
22
16
2358
2388
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy / Steelman, Linda S; Fitzgerald, Timothy; Lertpiriyapong, Kvin; Cocco, Lucio; Follo, Matilde Y; Martelli, Alberto M; Neri, Luca M; Marmiroli, Sandra; Libra, Massimo; Candido, Saverio; Nicoletti, Ferdinando; Scalisi, Aurora; Fenga, Concettina; Drobot, Lyudmyla; Rakus, Dariusz; Gizak, Agnieszka; Laidler, Piotr; Dulinska Litewka, Joanna; Basecke, Joerg; Mijatovic, Sanja; Maksimovic Ivanic, Danijela; Montalto, Giuseppe; Cervello, Melchiorre; Milella, Michelle; Tafuri, Agustino; Demidenko, Zoya; Abrams, Stephen L; Mccubrey, James A.. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1873-4286. - 22:16(2016), pp. 2358-2388. [10.2174/1381612822666160304151011]
Steelman, Linda S; Fitzgerald, Timothy; Lertpiriyapong, Kvin; Cocco, Lucio; Follo, Matilde Y; Martelli, Alberto M; Neri, Luca M; Marmiroli, Sandra; Libra, Massimo; Candido, Saverio; Nicoletti, Ferdinando; Scalisi, Aurora; Fenga, Concettina; Drobot, Lyudmyla; Rakus, Dariusz; Gizak, Agnieszka; Laidler, Piotr; Dulinska Litewka, Joanna; Basecke, Joerg; Mijatovic, Sanja; Maksimovic Ivanic, Danijela; Montalto, Giuseppe; Cervello, Melchiorre; Milella, Michelle; Tafuri, Agustino; Demidenko, Zoya; Abrams, Stephen L; Mccubrey, James A.
File in questo prodotto:
File Dimensione Formato  
McCubrey EGFR breast cancer CPD review 2016.pdf

non disponibili

Descrizione: main article
Tipologia: Versione pubblicata dall'editore
Dimensione 2.94 MB
Formato Adobe PDF
2.94 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1132159
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 28
social impact